Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Suspected gunman in Brown University shooting found dead
No evidence alleged Bondi gunmen received military training in Philippines
At least 12 killed in Nigeria mining site attack
Russian attack on Ukraine's central Cherkasy injures six, causes blackouts
UN, aid groups warn Gaza operations at risk from Israel impediments
Israel approves natural gas deal with Egypt, Netanyahu says
US approves $11.1 billion largest-ever arms package for Taiwan
Trump adds seven countries to full travel ban list
